https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Gene expression, copy number variation and DNA methylation associated with disease outcome in triple negative breast cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53830 Wed 13 Mar 2024 13:47:00 AEDT ]]> Copy number variation in triple negative breast cancer samples associated with lymph node metastasis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40665 Thu 28 Jul 2022 12:15:19 AEST ]]> Local therapy for triple-negative breast cancer: a comprehensive review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33647 Thu 27 Jan 2022 15:55:49 AEDT ]]> Tumor-infiltrating lymphocytes and prognosis: a poled individual patient analysis of early-stage triple-negative breast cancers https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34339 Mon 03 Feb 2020 11:52:07 AEDT ]]> MiRNAs and other epigenetic changes as biomarkers in triple negative breast cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:22586 Fri 10 Aug 2018 15:35:14 AEST ]]> The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32036 Fri 01 Apr 2022 09:24:05 AEDT ]]>